Precision Nanosystems US Inc.

Precision Nanosystems US Inc. is a for-profit corporate entity registered in SAM.gov, specializing in advanced nanotechnology equipment and instruments for biomedical research. The company provides sophisticated microfluidic and nanoparticle assembly systems that support critical scientific research across various federal agencies, particularly in the health and medical research domains. While specific details about the company's founding or full corporate history are not provided in the contract award data, the firm has demonstrated a consistent capability to deliver high-precision scientific instrumentation to leading federal research institutions.

The company has been awarded multiple federal contracts primarily from agencies within the Department of Health and Human Services, including the National Institutes of Health (NIH) and its specialized institutes like the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute, and National Human Genome Research Institute. Their primary product offerings include the NanoAssemblr Ignite Instrument, NanoAssemblr Spark Instrument, and NanoAssemblr NXGEN BLAZE Instrument, which are utilized for advanced research purposes such as coronavirus COVID-19 research, genomic studies, and biomedical research. Contract values have ranged from approximately $11,880 to $379,984, with most awards being firm fixed-price purchase orders. Most contracts were not set aside for specific business types, though one FDA contract was designated for total small business participation. The instruments are typically delivered to research facilities in locations like Bethesda, Maryland, and South San Francisco, California, supporting critical public health and medical research initiatives.